CN102920902A - 一种治疗鸡大肠杆菌病的中药及其制备方法 - Google Patents
一种治疗鸡大肠杆菌病的中药及其制备方法 Download PDFInfo
- Publication number
- CN102920902A CN102920902A CN2011103428737A CN201110342873A CN102920902A CN 102920902 A CN102920902 A CN 102920902A CN 2011103428737 A CN2011103428737 A CN 2011103428737A CN 201110342873 A CN201110342873 A CN 201110342873A CN 102920902 A CN102920902 A CN 102920902A
- Authority
- CN
- China
- Prior art keywords
- radix
- medical material
- mixing
- add
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 241000271566 Aves Species 0.000 title abstract description 4
- 239000008187 granular material Substances 0.000 claims abstract description 36
- 238000002156 mixing Methods 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 12
- 238000000605 extraction Methods 0.000 claims abstract description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 7
- 241000287828 Gallus gallus Species 0.000 claims description 28
- 239000012567 medical material Substances 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 108010059892 Cellulase Proteins 0.000 claims description 15
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 15
- 229940106157 cellulase Drugs 0.000 claims description 15
- 241000628997 Flos Species 0.000 claims description 14
- 239000010231 banlangen Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000012856 packing Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 7
- 208000001848 dysentery Diseases 0.000 abstract description 5
- 239000000843 powder Substances 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000000284 extract Substances 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 241000605445 Anemarrhena asphodeloides Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 241001071795 Gentiana Species 0.000 abstract 1
- 241001448331 Liriope spicata Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 206010059866 Drug resistance Diseases 0.000 description 11
- 241000588724 Escherichia coli Species 0.000 description 10
- 229940088710 antibiotic agent Drugs 0.000 description 6
- WEEMDRWIKYCTQM-UHFFFAOYSA-N 2,6-dimethoxybenzenecarbothioamide Chemical compound COC1=CC=CC(OC)=C1C(N)=S WEEMDRWIKYCTQM-UHFFFAOYSA-N 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 4
- 239000004375 Dextrin Substances 0.000 description 4
- 206010061126 Escherichia infection Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 235000019425 dextrin Nutrition 0.000 description 4
- 208000020612 escherichia coli infection Diseases 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 229960002385 streptomycin sulfate Drugs 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 208000003322 Coinfection Diseases 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 208000010359 Newcastle Disease Diseases 0.000 description 2
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 2
- 229960003321 baicalin Drugs 0.000 description 2
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- UXUFTKZYJYGMGO-CMCWBKRRSA-N (2s,3s,4r,5r)-5-[6-amino-2-[2-[4-[3-(2-aminoethylamino)-3-oxopropyl]phenyl]ethylamino]purin-9-yl]-n-ethyl-3,4-dihydroxyoxolane-2-carboxamide Chemical compound O[C@@H]1[C@H](O)[C@@H](C(=O)NCC)O[C@H]1N1C2=NC(NCCC=3C=CC(CCC(=O)NCCN)=CC=3)=NC(N)=C2N=C1 UXUFTKZYJYGMGO-CMCWBKRRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000022844 Bacterial Sexually Transmitted disease Diseases 0.000 description 1
- 208000027312 Bursal disease Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 229930189077 Rifamycin Natural products 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000001669 bursa of fabricius Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- NOCJXYPHIIZEHN-UHFFFAOYSA-N difloxacin Chemical compound C1CN(C)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1=CC=C(F)C=C1 NOCJXYPHIIZEHN-UHFFFAOYSA-N 0.000 description 1
- 229950001733 difloxacin Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005183 environmental health Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000003087 glucogenic effect Effects 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960003292 rifamycin Drugs 0.000 description 1
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical compound OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 试验鸡数(只) | 治愈数(只) | 无效数(只) | 治愈率(%) | 无效率(%) |
清解颗粒组 | 2200 | 1855 | 345 | 84.3a | 15.7 |
硫酸链霉素组 | 1000 | 865 | 150 | 86.5 | 13.5 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110342873.7A CN102920902B (zh) | 2011-11-03 | 2011-11-03 | 一种治疗鸡大肠杆菌病的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110342873.7A CN102920902B (zh) | 2011-11-03 | 2011-11-03 | 一种治疗鸡大肠杆菌病的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102920902A true CN102920902A (zh) | 2013-02-13 |
CN102920902B CN102920902B (zh) | 2014-11-19 |
Family
ID=47635927
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110342873.7A Expired - Fee Related CN102920902B (zh) | 2011-11-03 | 2011-11-03 | 一种治疗鸡大肠杆菌病的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102920902B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520285A (zh) * | 2013-09-27 | 2014-01-22 | 河南牧翔动物药业有限公司 | 一种兽用银连可溶性粉及其制备方法 |
CN105477312A (zh) * | 2015-12-25 | 2016-04-13 | 石家庄市九洲兽药有限公司 | 治疗鸡大肠杆菌病的中药组合物 |
CN106266684A (zh) * | 2016-08-26 | 2017-01-04 | 唐莹 | 一种治疗鸡大肠杆菌病的中兽药制剂 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1215610A (zh) * | 1998-10-16 | 1999-05-05 | 湖南正清制药集团股份有限公司 | 一种清热解毒颗粒剂及其制备方法 |
CN1927272A (zh) * | 2005-09-09 | 2007-03-14 | 天津市润拓生物技术有限公司 | 一种具有清热解毒、消肿散结功能的兽用药剂及其制法 |
CN101390920A (zh) * | 2007-09-21 | 2009-03-25 | 天津生机集团有限公司 | 一种畜禽用中药消炎药及其制备方法 |
CN101693022A (zh) * | 2009-10-27 | 2010-04-14 | 赵正福 | 具有防治类风湿性关节炎的白藜芦醇缓释胶囊的制备方法 |
-
2011
- 2011-11-03 CN CN201110342873.7A patent/CN102920902B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1215610A (zh) * | 1998-10-16 | 1999-05-05 | 湖南正清制药集团股份有限公司 | 一种清热解毒颗粒剂及其制备方法 |
CN1927272A (zh) * | 2005-09-09 | 2007-03-14 | 天津市润拓生物技术有限公司 | 一种具有清热解毒、消肿散结功能的兽用药剂及其制法 |
CN101390920A (zh) * | 2007-09-21 | 2009-03-25 | 天津生机集团有限公司 | 一种畜禽用中药消炎药及其制备方法 |
CN101693022A (zh) * | 2009-10-27 | 2010-04-14 | 赵正福 | 具有防治类风湿性关节炎的白藜芦醇缓释胶囊的制备方法 |
Non-Patent Citations (1)
Title |
---|
李国旺等: "5味中药对鸡大肠杆菌的体外抑菌试验", 《贵州农业科学》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520285A (zh) * | 2013-09-27 | 2014-01-22 | 河南牧翔动物药业有限公司 | 一种兽用银连可溶性粉及其制备方法 |
CN105477312A (zh) * | 2015-12-25 | 2016-04-13 | 石家庄市九洲兽药有限公司 | 治疗鸡大肠杆菌病的中药组合物 |
CN105477312B (zh) * | 2015-12-25 | 2019-03-08 | 石家庄市九洲兽药有限公司 | 治疗鸡大肠杆菌病的中药组合物 |
CN106266684A (zh) * | 2016-08-26 | 2017-01-04 | 唐莹 | 一种治疗鸡大肠杆菌病的中兽药制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN102920902B (zh) | 2014-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103125779A (zh) | 一种肉鸡用生物中药饲料添加剂及其制备方法 | |
CN104522320B (zh) | 一种天然植物抗球虫饲料添加剂及其应用 | |
CN102228636B (zh) | 治疗高致病性蓝耳病的中药组合物 | |
CN110559363A (zh) | 一种防治非洲猪瘟的中药复方发酵口服液及其制备工艺 | |
CN102319297B (zh) | 一种治疗畜禽和鱼类疾病的中兽药 | |
CN101209297A (zh) | 一种用于治疗鸡球虫病的复方中药颗粒剂 | |
CN102920902B (zh) | 一种治疗鸡大肠杆菌病的中药及其制备方法 | |
CN104208239B (zh) | 一种用于防治家禽大肠杆菌疾病的中药组合物、微生态制剂及制备方法 | |
CN102091151B (zh) | 具有疏风祛湿功能的中药组合物及其制备方法 | |
CN103272091A (zh) | 一种治疗鸡球虫病的中药口服制剂及其制备方法 | |
WO2020155318A1 (zh) | 一种治疗家畜细菌性呼吸道疫病的中药制剂及其生产工艺 | |
CN103495136A (zh) | 一种治疗畜禽胃肠道寄生虫病的发酵中草药及其制备方法 | |
CN112022980A (zh) | 一种预防非洲猪瘟病毒的中药配方及其药剂制备工艺 | |
CN103191282B (zh) | 一种用于治疗小儿发热的中药组合物及制备方法和应用 | |
CN102895503B (zh) | 一种治疗鸡大肠杆菌感染引起的热毒症的颗粒剂及其制备方法 | |
CN102488754A (zh) | 一种具有抗病菌作用的渔用中药组合物及其制备方法 | |
CN111588801B (zh) | 一种预防畜禽疫病的中药分散颗粒剂及其制备方法 | |
CN103463395A (zh) | 一种治疗鸡呼吸道疾病的药物配方 | |
CN103893523A (zh) | 一种防治鸡热毒症的中兽药制剂及其制备方法与应用 | |
CN103127313A (zh) | 治疗艾滋病的冻干三叶青 | |
CN109432287B (zh) | 一种防治家禽气分热盛证的中药口服液及其制备方法 | |
CN101721437B (zh) | 用于治疗慢性咽炎的药物组合物的制备方法 | |
CN102697959A (zh) | 一种预防和治疗猪呼吸道病综合症的中兽药 | |
CN104758390A (zh) | 防治猪腹泻的植物药复方制剂及其制备方法 | |
CN103211878B (zh) | 一种抗感染的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 266061 Shandong province hi tech park of Laoshan Mountain district by the Shandong Road No. 29 building 12F high speed Applicant after: QINGDAO VLAND BIOTECH Inc. Applicant after: Qingdao Agricultural University Address before: 266061 Shandong city of Qingdao province high tech park of Laoshan district by the No. 29 Shandong Road, building 606 high speed Applicant before: QINGDAO KDN PHARMACEUTICAL Co.,Ltd. Applicant before: Qingdao Agricultural University |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: QINGDAO KDN PHARMACEUTICAL CO., LTD. TO: QINGDAO WEILAN BIOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141119 |